These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 7337980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A, Szabó G, Csongor J, Sonkoly I, Szegedi G.
    Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G, Jonsson H, Sjöholm A, Sturfelt G, Svehag SE.
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH, Liu HW, Lin SF, Chen JR, Chen TP.
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K, Doi T, Muso E, Yoshida H, Kanatsu K, Hamashima Y.
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [Abstract] [Full Text] [Related]

  • 15. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE, Moss IK, Mumford P, Horsfall A, Maini RN.
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [Abstract] [Full Text] [Related]

  • 16. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J, Sølling K, Jacobsen KU.
    Acta Derm Venereol; 1979 Jun; 59(5):421-6. PubMed ID: 93365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 19. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ, Steinsson K, Kolka R, Víkingsdóttir T, D'Ambrogio MS, Valdimarsson H.
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [Abstract] [Full Text] [Related]

  • 20. Kinetic analysis of immune complex solubilization: complement function in relation to disease activity in SLE.
    Sturfelt G, Nived O, Sjöholm AG.
    Clin Exp Rheumatol; 1992 Jun; 10(3):241-7. PubMed ID: 1582069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.